- Home
- VTSI vs PLRX Comparison
VTSI vs PLRX Comparison
Compare VTSI & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTSI
- PLRX
- Stock Information
- Founded
- VTSI 1993
- PLRX 2015
- Country
- VTSI United States
- PLRX United States
- Employees
- VTSI N/A
- PLRX N/A
- Industry
- VTSI Miscellaneous manufacturing industries
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- VTSI Consumer Discretionary
- PLRX Health Care
- Exchange
- VTSI Nasdaq
- PLRX Nasdaq
- Market Cap
- VTSI 67.3M
- PLRX 77.3M
- IPO Year
- VTSI N/A
- PLRX 2020
- Fundamental
- Price
- VTSI $6.20
- PLRX $1.57
- Analyst Decision
- VTSI Strong Buy
- PLRX Hold
- Analyst Count
- VTSI 1
- PLRX 10
- Target Price
- VTSI $7.00
- PLRX $9.79
- AVG Volume (30 Days)
- VTSI 151.6K
- PLRX 1.9M
- Earning Date
- VTSI 08-11-2025
- PLRX 08-06-2025
- Dividend Yield
- VTSI N/A
- PLRX N/A
- EPS Growth
- VTSI N/A
- PLRX N/A
- EPS
- VTSI 0.19
- PLRX N/A
- Revenue
- VTSI $26,164,645.00
- PLRX N/A
- Revenue This Year
- VTSI $9.92
- PLRX N/A
- Revenue Next Year
- VTSI $16.54
- PLRX N/A
- P/E Ratio
- VTSI $32.66
- PLRX N/A
- Revenue Growth
- VTSI N/A
- PLRX N/A
- 52 Week Low
- VTSI $3.57
- PLRX $1.10
- 52 Week High
- VTSI $8.98
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- VTSI 49.46
- PLRX 62.56
- Support Level
- VTSI $5.81
- PLRX $1.55
- Resistance Level
- VTSI $6.35
- PLRX $1.64
- Average True Range (ATR)
- VTSI 0.27
- PLRX 0.11
- MACD
- VTSI -0.05
- PLRX 0.03
- Stochastic Oscillator
- VTSI 43.33
- PLRX 85.11
About VTSI VirTra Inc.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.